Nitric oxide synthase gene therapy in vascular pathology

Area of Science:

• Vascular Biology
• Molecular Medicine
• Gene Therapy

Background:

• Nitric oxide (NO) is crucial for vascular homeostasis, exhibiting antiplatelet, antiproliferative, and vasodilating effects.
• Vascular injury responses, like intimal hyperplasia, are significant clinical challenges.
• Harnessing NO's properties for therapeutic benefit is an active area of research.

Purpose of the Study:

• To investigate the potential of gene transfer for local nitric oxide synthesis to prevent vascular injury.
• To elucidate the cellular mechanisms by which NO inhibits smooth muscle cell proliferation and intimal hyperplasia.

Main Methods:

• Gene delivery of inducible nitric oxide synthase (iNOS) cDNA to sites of vascular injury in animal models.
• Analysis of cellular mechanisms, including cyclic guanosine monophosphate (cGMP) production, p21 and p53 expression, and mitogen-activated protein kinase (MAPK) activation.

Main Results:

• Gene delivery of iNOS significantly reduced smooth muscle proliferation and intimal hyperplasia in animal models.
• NO-mediated inhibition of smooth muscle cell proliferation was independent of cGMP.
• NO upregulated the cell cycle inhibitor p21, independent of p53, via p42/44 MAPK activation.

Conclusions:

• Local NO synthesis via iNOS gene transfer is a promising strategy to prevent intimal hyperplasia.
• NO inhibits smooth muscle cell proliferation by inducing cell cycle arrest through p21 upregulation.
• The p42/44 MAPK pathway is implicated in NO-mediated p21 upregulation and subsequent antiproliferative effects.